A Study of BBI608 Administered in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Cancers
Clinical trial NCT02467361 · COMPLETED
Trial details
- NCT number
- NCT02467361
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2021-01-29
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.